Oh wait. They are talking about Nemeroff and Biederman on today’s New York Times editorial page.
A prominent psychiatrist at Emory University is accused of taking large payments from a drug maker — and misleading his university about the amounts — while heading a government study of the company’s antidepressant drugs. Three psychiatrists at Harvard whose work fueled an explosion in the use of powerful antipsychotic drugs to treat children are accused of failing to report large payments from the drug makers, most of which they had not disclosed to their institutions.
You can’t buy this kind of publicity.
